These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26539246)

  • 41. Comprehensive characterization of immune- and inflammation-associated biomarkers based on multi-omics integration in kidney renal clear cell carcinoma.
    Zhao E; Li L; Zhang W; Wang W; Chan Y; You B; Li X
    J Transl Med; 2019 May; 17(1):177. PubMed ID: 31133033
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systematic analysis of survival-associated alternative splicing signatures in clear cell renal cell carcinoma.
    Chen T; Zheng W; Chen J; Lin S; Zou Z; Li X; Tan Z
    J Cell Biochem; 2020 Oct; 121(10):4074-4084. PubMed ID: 31886566
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immune associated LncRNAs identify novel prognostic subtypes of renal clear cell carcinoma.
    Khadirnaikar S; Kumar P; Pandi SN; Malik R; Dhanasekaran SM; Shukla SK
    Mol Carcinog; 2019 Apr; 58(4):544-553. PubMed ID: 30520148
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel lincRNA SLINKY is a prognostic biomarker in kidney cancer.
    Gong X; Siprashvili Z; Eminaga O; Shen Z; Sato Y; Kume H; Homma Y; Ogawa S; Khavari PA; Pollack JR; Brooks JD
    Oncotarget; 2017 Mar; 8(12):18657-18669. PubMed ID: 28423633
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A 44-gene set constructed for predicting the prognosis of clear cell renal cell carcinoma.
    Wang Y; Wang Y; Liu F
    Int J Mol Med; 2018 Dec; 42(6):3105-3114. PubMed ID: 30272265
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Higher programmed cell death 1 ligand 1 (PD-L1) mRNA level in clear cell renal cell carcinomas is associated with a favorable outcome due to the active immune responses in tumor tissues.
    Ning XH; Gong YQ; He SM; Li T; Wang JY; Peng SH; Chen JC; Liu JY; Qi NN; Guo YL; Gong K
    Oncotarget; 2017 Jan; 8(2):3355-3363. PubMed ID: 27926518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sex-specific survival gene mutations are discovered as clinical predictors of clear cell renal cell carcinoma.
    Hwang J; Lee HE; Han JS; Choi MH; Hong SH; Kim SW; Yang JH; Park U; Jung ES; Choi YJ
    Sci Rep; 2024 Jul; 14(1):15800. PubMed ID: 38982123
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
    Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
    Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of Six Potentially Long Noncoding RNAs as Biomarkers Involved Competitive Endogenous RNA in Clear Cell Renal Cell Carcinoma.
    Yang K; Lu XF; Luo PC; Zhang J
    Biomed Res Int; 2018; 2018():9303486. PubMed ID: 30406146
    [No Abstract]   [Full Text] [Related]  

  • 50. Downregulation of enhancer RNA EMX2OS is associated with poor prognosis in kidney renal clear cell carcinoma.
    Jiang H; Chen H; Wan P; Song S; Chen N
    Aging (Albany NY); 2020 Nov; 12(24):25865-25877. PubMed ID: 33234727
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Upregulated Transcription Factor PITX1 Predicts Poor Prognosis in Kidney Renal Clear Cell Carcinoma-Based Bioinformatic Analysis and Experimental Verification.
    Zhang Y; Zhang Z; Zhang W; Hu H; Bao G
    Dis Markers; 2021; 2021():7694239. PubMed ID: 34868397
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma.
    Liu T; Sui J; Zhang Y; Zhang XM; Wu WJ; Yang S; Xu SY; Hong WW; Peng H; Yin LH; Pu YP; Liang GY
    Oncol Rep; 2018 Sep; 40(3):1503-1514. PubMed ID: 30015930
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinoma.
    Chen G; Wang Y; Wang L; Xu W
    Oncotarget; 2017 Jan; 8(3):5268-5280. PubMed ID: 28029655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. OSkirc: a web tool for identifying prognostic biomarkers in kidney renal clear cell carcinoma.
    Xie L; Wang Q; Dang Y; Ge L; Sun X; Li N; Han Y; Yan Z; Zhang L; Li Y; Zhang H; Guo X
    Future Oncol; 2019 Sep; 15(27):3103-3110. PubMed ID: 31368353
    [No Abstract]   [Full Text] [Related]  

  • 56. Identification of a 5-Gene Signature Predicting Progression and Prognosis of Clear Cell Renal Cell Carcinoma.
    Pan Q; Wang L; Zhang H; Liang C; Li B
    Med Sci Monit; 2019 Jun; 25():4401-4413. PubMed ID: 31194719
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic value of cross-omics screening for kidney clear cell renal cancer survival.
    Dimitrieva S; Schlapbach R; Rehrauer H
    Biol Direct; 2016 Dec; 11(1):68. PubMed ID: 27993167
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low level of PDZ domain containing 1 (PDZK1) predicts poor clinical outcome in patients with clear cell renal cell carcinoma.
    Zheng J; Wang L; Peng Z; Yang Y; Feng D; He J
    EBioMedicine; 2017 Feb; 15():62-72. PubMed ID: 27993630
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Construction autophagy-related prognostic risk signature combined with clinicopathological validation analysis for survival prediction of kidney renal papillary cell carcinoma patients.
    Fei H; Chen S; Xu C
    BMC Cancer; 2021 Apr; 21(1):411. PubMed ID: 33858375
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression patterns and prognostic value of RUNX genes in kidney cancer.
    Gao K; Zhang F; Chen K; Li W; Guan YB; Xu ML; Chong T; Dai ZM
    Sci Rep; 2021 Jul; 11(1):14934. PubMed ID: 34294773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.